2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keyword Index<br />
Polymalformations: P03.086<br />
polymicrogyria, autosomal recessive,:<br />
P02.112<br />
polymicrogyria: P02.098<br />
polymorphic ventricular tachycardia:<br />
P12.144<br />
polymorphism R577X: P01.01<br />
polymorphism: P04.13, P04.19, P04.28,<br />
P04.30, P05.31, P06.011, P06.029,<br />
P06.041, P06.042, P06.055, P06.067,<br />
P06.088, P06.129, P06.178, P08.39,<br />
P08.56, P08.61, P09.003, P09.088,<br />
P09.102, P09.118, P09.124, P10.15,<br />
P10.18, P10.19, P10.57, P17.24, P17.40<br />
polymorphisms: P02.010, P03.020,<br />
P04.05, P06.039, P06.070, P06.094,<br />
P06.134, P06.143, P08.14, P09.011,<br />
P09.079, P12.062<br />
polyposis coli: P06.153<br />
polyposis: P09.038, P12.129<br />
POMGnT1: P05.41<br />
PON1: P10.13<br />
pontocerebellar hypoplasia: C03.5<br />
Pooling: C01.5<br />
population carrier screening: C18.4<br />
population differentiation: P08.19<br />
population genetics: P10.70, P10.76<br />
population <strong>of</strong> Lithuania: P09.026<br />
population screening: P01.17, P06.148<br />
population study: P10.88<br />
population: P09.006<br />
Population-based longitudinal study:<br />
P10.79<br />
PORCN gene: P02.038<br />
PORCN: P12.063<br />
Porencephaly: P12.131<br />
Portuguese: P06.122<br />
position effect: P11.020<br />
positional effect: P03.096<br />
position-effect variegation: P03.143<br />
POU3F4: P12.076<br />
power performance: P09.015, P09.129<br />
powerlifting: P09.022<br />
PPAC: P02.105<br />
PPARG: P11.095<br />
PPAR-α: P17.44<br />
PQBP1: P02.199<br />
Prader Willi syndrome: P03.172<br />
Prader Willi/Angelman Syndrome: P01.39<br />
Prader Willi: P03.171, P14.16<br />
Prader-Willi syndrome: P03.175<br />
Prader–Willi/Angelman syndromes:<br />
P03.173<br />
Prader-Willi: P03.174<br />
pre- and protomutations: P16.53<br />
Preaxial Polydactyly: P11.096<br />
preclinical diagnostics: P08.52<br />
predictive genetic testing: P08.33<br />
Predictive testing: P01.21, S03.1<br />
predictive value: P06.014<br />
Preeclampsia: P04.18, P04.19, P05.08,<br />
P05.18, P05.19, P11.097<br />
pregnant: P04.31<br />
Preimplantation genetic diagnosis:<br />
P03.132, P04.15, P05.50, P05.52<br />
Preimplantation: S09.3<br />
premarital screening program: P01.40<br />
premature aging: P02.023<br />
premature centromere separation: P02.102<br />
Premature ovarian failure: C11.4, P04.20,<br />
P04.21, P04.22, P09.099<br />
premature: P02.027<br />
pre-mRNA processing: S02.3<br />
Premutation: P03.153<br />
Prenatal biochemical screening: P05.25<br />
Prenatal diagnosis: P01.41, P02.120,<br />
P02.121, P02.175, P03.046, P05.06,<br />
P05.12, P05.13, P05.26, P05.27, P05.32,<br />
P05.36, P05.43, P05.56, P05.60, P08.58,<br />
P10.25, P16.33, S09.2<br />
prenatal diagnostics: P04.23, P05.28<br />
prenatal evaluation: P05.29<br />
prenatal screening policy: C07.6<br />
prenatal screening: P05.35<br />
prenatal: C07.5, P01.11, P03.113, P05.53,<br />
S09.3<br />
Prenental: P02.172<br />
Prestige oil spill: P03.026<br />
pre-synaptic protein Piccolo: C05.2<br />
prevalence: P02.163<br />
prevention: P14.02<br />
preventive thyroidectomy.: P06.061<br />
Primary arrhythmia syndrome: C13.2<br />
primary care: P01.23<br />
primary cilia: P02.086<br />
Primary ciliary dyskinesia: C12.6<br />
Primary congenital lymphoedema: P12.132<br />
primary cutaneous amyloidosis: P08.53<br />
Primary hypertrophic osteoarthropathy:<br />
P02.157<br />
primitive neuroectodermal tumor: P06.071<br />
Primordial dwarfism: P02.001<br />
pr<strong>of</strong>essional athletes: P10.69<br />
Progesterone Receptor gene: P06.135<br />
prognosis: P09.082<br />
prognostic: P06.204<br />
prognostically important chromosomal<br />
aberrations: P06.166<br />
promoter function: P11.103<br />
promoter polymorphism: P10.82<br />
Promoter: P02.198, P12.094<br />
properdin: P09.005<br />
prophylactic laparoscopic gastrectomy:<br />
P06.045<br />
prophylaxis: C18.3<br />
propionic acidemia: P12.133<br />
Prostaglandin: P02.157<br />
Prostate cancer (PCa): P06.077<br />
Prostate cancer: P06.028, P06.029,<br />
P06.072, P06.073, P06.074, P06.075,<br />
P06.076, P06.087<br />
protamine gene: P04.30<br />
Protein: P11.098<br />
Protein–Protein interaction: P11.093<br />
protein-protein interaction: P12.134<br />
protein-protein-interaction: C04.4<br />
Proteus syndrome: P12.135<br />
protrombin: P14.17<br />
proximal 3q deletion: P03.076<br />
proximal 6q deletion: P03.077<br />
proximal deletion 3p: P03.073<br />
PSEN1: P12.014<br />
PSEN2: P12.014<br />
pseudomosaicism: P03.047<br />
Pseudoxanthoma elasticum: P12.136<br />
psoriasis: P10.46<br />
Psoriatic arthritis: P09.100, P09.101,<br />
P09.102<br />
PTCH: P06.007<br />
PTEN gene: P06.028, P12.135<br />
PTEN: P06.048, P06.078<br />
PTHR1 gene: P02.158<br />
PTPN11 gene: P02.135<br />
PTPN11: P02.133, P02.141, P02.142,<br />
P02.143, P02.146, P02.147<br />
PTPN22 gene: P09.104, P09.105<br />
PTPN22: P08.54, P09.103, P11.099,<br />
P17.02<br />
public attitude: P01.42<br />
Public Engagement: P01.43<br />
public health: P01.44<br />
public opinion: P01.02<br />
pulmonary arterial hypertension: P17.37<br />
pulse wave analysis: P08.10<br />
purples <strong>of</strong> Schamberg: P02.113<br />
purples <strong>of</strong> Shenlejna-Genoh: P02.113<br />
P-value combination: P17.28<br />
Pycnodysostosis: P02.159<br />
pyramidal tetraparesis: P14.04<br />
Q<br />
QF PCR: P05.58, P12.158<br />
QF-PCR: P02.002, P05.55, P05.59,<br />
P05.60, P05.61<br />
QF-PCR;: P03.055<br />
QMPSF: P03.175<br />
qPCR: P11.019, P11.100<br />
qPCR-HRM: P06.079